Archives
[Abstract Only] Avelumab maintenance therapy for advanced or metastatic urothelial carcinoma
20 Sep, 2020 | 21:11h | UTC
Commentary on Twitter
Maintenance avelumab plus best supportive care significantly prolonged overall survival, as compared with best supportive care alone, among patients with urothelial cancer who had disease that had not progressed with first-line chemotherapy. #ESMO20
— NEJM (@NEJM) September 18, 2020
Pulmonary embolism in patients with coronavirus disease-2019 (COVID-19) pneumonia: A narrative review
18 Sep, 2020 | 09:39h | UTC
The pooled prevalence of pulmonary embolism in patients with COVID-19
18 Sep, 2020 | 09:37h | UTCThe pooled prevalence of pulmonary embolism in patients with COVID-19 – Intensive Care Medicine
Commentary on Twitter
Pulmonary embolism in #COVID19, be careful! quantitative meta-analysis ->
pooled prevalence in pts undergoing #PE diagnosis 28%
higher pooled prevalence in pts admitted to #ICU vs those admitted to non-ICU: 19 vs 9%
Open access @yourICM #COVIDFOAM #FOAMcc https://t.co/dUqKAVoeCV pic.twitter.com/fvmQnTlv1M— Intensive Care Medicine (@yourICM) September 15, 2020
Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong
18 Sep, 2020 | 09:34h | UTCClustering and superspreading potential of SARS-CoV-2 infections in Hong Kong – Nature Medicine
Commentary: Superspreaders of SARS-CoV-2 – Virology Blog
Commentaries on Twitter
Cases linked to #superspreading events are estimated to account for 80% of all local transmission of #SARSCoV2 in Hong Kong in a study with implications for public health policies. @bencowling88 @gmleunghku @SCauchemez @DillonCAdam @hkumed #quarantinehttps://t.co/tniPhKNhs5
— Nature Medicine (@NatureMedicine) September 17, 2020
We can learn a lot about superspreader events from this new @NatureMedicine paper https://t.co/ouO7CyGXQE by @DillonCAdam @bencowling88 @gmleunghku @hkumed
The Pareto 80/20 rule applied: 19% of infections were responsible for 80% of transmissions; 69% of cases did not transmit— Eric Topol (@EricTopol) September 17, 2020
Covid-19: Do many people have pre-existing immunity?
18 Sep, 2020 | 09:41h | UTCCovid-19: Do many people have pre-existing immunity? – The BMJ
Commentary on Twitter
It seemed a truth universally acknowledged that the human population had no pre-existing immunity to SARS-CoV-2, but is that actually the case? Peter Doshi explores the emerging research on immunological responseshttps://t.co/6LYRjxlWBQ
— The BMJ (@bmj_latest) September 17, 2020
Change in antibodies to SARS-CoV-2 over 60 days among health care personnel
18 Sep, 2020 | 09:32h | UTC
Commentary on Twitter
In this cohort study, anti–SARS-CoV-2 antibodies decreased over 60d in HCWs w 58% becoming seronegative. The results suggest that x-sectional seroprevalence studies may underestimate rates of prior infections because Abs may only be transiently detectable https://t.co/IHgURuDJYm
— JAMA (@JAMA_current) September 18, 2020
The new Covid-19 case surge in Europe, explained
18 Sep, 2020 | 09:29h | UTCThe new Covid-19 case surge in Europe, explained – Vox
ESC Position Paper: Integration of a palliative approach into heart failure care
18 Sep, 2020 | 09:24h | UTC
Commentary on Twitter
Palliative care should be part of every #heartfailure management programme. Read about how you can discuss and implement it in #EJHF https://t.co/lpR3Jb1I9p@MarcoMetra @HFA_President @kevin_damman pic.twitter.com/tA9nCMHiyS
— European Society of Cardiology Journals (@ESC_Journals) September 17, 2020
Cochrane publishes three rapid reviews of the evidence on different public health measures to slow the spread of COVID-19
18 Sep, 2020 | 09:33h | UTCSee update reviews: How effective is screening for COVID-19? AND Can travel-related control measures contain the spread of the COVID-19 pandemic? AND Does quarantine control coronavirus (COVID-2019) either alone or in combination with other public health measures?
Commentary on Twitter
📣 3 rapid reviews of the evidence on different #publichealth measures to slow the spread of COVID-19 https://t.co/QShfHABEpL Quarantine, travel-related control measures, and Universal screening. – Open-access in @CochraneLibrary – #COVID #COVID19 pic.twitter.com/HqyQtYErfK
— The Cochrane Library (@CochraneLibrary) September 17, 2020
WHO: Keep health workers safe to keep patients safe
18 Sep, 2020 | 09:26h | UTCKeep health workers safe to keep patients safe – World Health Organization
See also: World Patient Safety Day Campaign
Commentaries on Twitter
No country, hospital or clinic can keep patients safe unless it keeps #healthworkers safe.
Today, @WHO launched a health worker safety charter to ensure they have safe working conditions, training, pay & the respect they deserve.https://t.co/3Fks43r4JN #WorldPatientSafetyDay— Tedros Adhanom Ghebreyesus (@DrTedros) September 17, 2020
Two pharma companies released their coronavirus vaccine blueprints in a bid to regain public trust
18 Sep, 2020 | 09:30h | UTC
Not necessary. 5 policy ideas for limiting low-value care in Canada
18 Sep, 2020 | 09:23h | UTCNot Necessary. Policy Ideas for Limiting Low-Value Care in Canada – Choosing Wisely Canada
Commentary on Twitter
#ChoosingWisely🇨🇦 has released 5 policy ideas to address in the short, medium, and long-term to limit low-value care in Canada during the pandemic and beyond.
Read now: https://t.co/fSTAe2ZvFM
— Choosing Wisely Canada (@ChooseWiselyCA) September 17, 2020
Viable SARS-CoV-2 in the air of a hospital room with COVID-19 patients
18 Sep, 2020 | 09:27h | UTC
Commentary on Twitter
More evidence for aerosol transmission "Viable #SARSCoV2 isolated from air samples 2-4.8 m away from patients…genome sequence isolated from material collected by air samplers identical to isolates from newly admitted patient". https://t.co/mvPJEmvMjV
— MJA Editor in Chief (@MJA_Editor) September 18, 2020
Study: Longer-than-necessary duration of outpatient antibiotic therapy for common outpatient infections
18 Sep, 2020 | 09:21h | UTC
Commentary on Twitter
NEW #CID using large NDTI dataset,clinicians defaulted 10d courses for most conditions, regardless of guideline-recommendations. Median antibiotic course
duration was 10 days for all conditions except acute cystitis. #IDTwitter https://t.co/WTJBFEcRtk pic.twitter.com/TAx7twUoTo— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) September 16, 2020
WHO Guidance: Allocation and prioritization of COVID-19 vaccination
17 Sep, 2020 | 09:42h | UTCCommentary: World Health Organization announces distribution plan for COVID-19 vaccine – ABD News
Related: An ethical framework for global vaccine allocation – Science
A case of probable Parkinson’s disease after SARS-CoV-2 infection
17 Sep, 2020 | 09:40h | UTCA case of probable Parkinson’s disease after SARS-CoV-2 infection – The Lancet Neurology
Commentary on Twitter
Parkinson's disease diagnosed after #SARSCoV2 in a 45 year-old-man https://t.co/SPLKDm1A2U @TheLancetNeuro
This has been reported with many other viruses but appears to be the 1st case with covid, very extensive workup pic.twitter.com/AtQfQXxjtm— Eric Topol (@EricTopol) September 17, 2020
How COVID-19 can damage the brain
17 Sep, 2020 | 09:36h | UTCHow COVID-19 can damage the brain – Nature
Commentary on Twitter
How COVID-19 can damage the brain https://t.co/uQUS5y9AXU 125 people in the United Kingdom with COVID-19 who had neurological or psychiatric effects. 62% had strokes and haemorrhages, and 31% had altered mental states, such as confusion or prolonged unconsciousness.
— Carlos del Rio (@CarlosdelRio7) September 16, 2020
Antimicrobial resistance: The next big pandemic?
18 Sep, 2020 | 09:19h | UTCAntimicrobial resistance: The next big pandemic? – Open Access Government
Detection of SARS-CoV-2 with a CRISPR-based test
17 Sep, 2020 | 09:38h | UTCDetection of SARS-CoV-2 with a CRISPR-Based Test – New England Journal of Medicine
Fast coronavirus tests: what they can and can’t do
17 Sep, 2020 | 09:35h | UTCFast coronavirus tests: what they can and can’t do – Nature
Opinion: “Is lockdown worth the pain? No, it’s a sledgehammer and we have better options”
17 Sep, 2020 | 09:31h | UTCIs lockdown worth the pain? No, it’s a sledgehammer and we have better options – The Conversation
[Press release – not published yet] Eli Lilly reports first, promising results for an antibody against COVID-19
17 Sep, 2020 | 09:28h | UTCEli Lilly reports first, promising results for an antibody against COVID-19 – Science
Press release: Lilly announces proof of concept data for neutralizing antibody LY-CoV555 in the COVID-19 outpatient setting
Updated Cochrane Rapid Review assesses the effectiveness of quarantine during the COVID-19 pandemic
17 Sep, 2020 | 09:32h | UTC
Commentary on Twitter
Recently published: https://t.co/lLM4ehhyro Updated @cochranecollab Rapid Review assesses the effectiveness of #quarantine during the #COVID-19 pandemic. It includes 51 relevant studies – 22 more than in the first version. @CochraneAus pic.twitter.com/ME5CiuTzUa
— The Cochrane Library (@CochraneLibrary) September 16, 2020
CDC Study: Characteristics and maternal and birth outcomes of hospitalized pregnant women with laboratory-confirmed COVID-19
17 Sep, 2020 | 09:29h | UTC
Commentary on Twitter
.@CDCMMWR report looking at almost 600 hospitalized pregnant women with #COVID19 found that pregnant women can have severe illness and poor birth outcomes, such as the mother requiring intensive care, pregnancy loss, and preterm birth. Learn more: https://t.co/g7WsFWJdDs. pic.twitter.com/Ve0dnGNTDM
— CDC (@CDCgov) September 16, 2020
When to replicate systematic reviews of interventions: Consensus checklist
17 Sep, 2020 | 09:23h | UTCWhen to replicate systematic reviews of interventions: consensus checklist – The BMJ
Commentary on Twitter
Delighted this is out today! Thanks to @CIHR_IRSC funding and great team: When to replicate systematic reviews of interventions: consensus checklist https://t.co/1WDc9a6VBq
— Vivian A Welch (@vawelch) September 15, 2020